{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:00:12Z","timestamp":1790305212452,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,1,12]],"date-time":"2010-01-12T00:00:00Z","timestamp":1263254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s11695-009-0051-0","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T14:55:15Z","timestamp":1263221715000},"page":"1400-1407","source":"Crossref","is-referenced-by-count":21,"title":["Hypoadiponectinemia and its Association with Liver Fibrosis in Morbidly Obese Patients"],"prefix":"10.1007","volume":"20","author":[{"given":"Leyla","family":"Nazal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoldo","family":"Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Sol\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Escalona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Burotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Saint-Jean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Concha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Awruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Baudrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Ang\u00e9lica","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oslando","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Francisco","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Nervi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,12]]},"reference":[{"key":"51_CR1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221\u201331.","journal-title":"N Engl J Med"},{"key":"51_CR2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","volume":"25","author":"P Angulo","year":"2007","unstructured":"Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2007;25:883\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"51_CR3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01823.x","volume":"29","author":"A Riquelme","year":"2009","unstructured":"Riquelme A, Arrese M, Soza A, et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int. 2009;29:82\u20138.","journal-title":"Liver Int"},{"issue":"Suppl 1","key":"51_CR4","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1038\/modpathol.3800680","volume":"20","author":"EM Brunt","year":"2007","unstructured":"Brunt EM. Pathology of fatty liver disease. Mod Pathol. 2007;20 Suppl 1:S40\u20138.","journal-title":"Mod Pathol"},{"key":"51_CR5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413\u20139.","journal-title":"Gastroenterology"},{"key":"51_CR6","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/hep.1840220616","volume":"22","author":"MR Teli","year":"1995","unstructured":"Teli MR, James OF, Burt AD, et al. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995;22:1714\u20139.","journal-title":"Hepatology"},{"key":"51_CR7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","volume":"135","author":"GP Aithal","year":"2008","unstructured":"Aithal GP, Thomas JA, Kaye PV, et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology. 2008;135:1176\u201384.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"51_CR8","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jhep.2008.01.009","volume":"48","author":"NM Alwis de","year":"2008","unstructured":"de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48 Suppl 1:S104\u201312.","journal-title":"J Hepatol"},{"key":"51_CR9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","volume":"123","author":"E Bugianesi","year":"2002","unstructured":"Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134\u201340.","journal-title":"Gastroenterology"},{"key":"51_CR10","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99\u2013112.","journal-title":"Hepatology"},{"key":"51_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","volume":"11","author":"JP Ong","year":"2007","unstructured":"Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis. 2007;11:1\u201316. vii.","journal-title":"Clin Liver Dis"},{"key":"51_CR12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmed.2007.12.003","volume":"14","author":"F Marra","year":"2008","unstructured":"Marra F, Gastaldelli A, Svegliati Baroni G. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med. 2008;14:72\u201381.","journal-title":"Trends Mol Med"},{"key":"51_CR13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/hep.22783","volume":"49","author":"M Arrese","year":"2009","unstructured":"Arrese M. Burning hepatic fat: therapeutic potential for liver-specific thyromimetics in the treatment of nonalcoholic fatty liver disease. Hepatology. 2009;49:348\u201351.","journal-title":"Hepatology"},{"key":"51_CR14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ncpendmet0505","volume":"3","author":"G Perlemuter","year":"2007","unstructured":"Perlemuter G, Bigorgne A, Cassard-Doulcier AM, et al. Nonalcoholic fatty liver disease: from pathogenesis to patient care. Nat Clin Pract Endocrinol Metab. 2007;3:458\u201369.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"51_CR15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1566524053766022","volume":"5","author":"P Arner","year":"2005","unstructured":"Arner P. Insulin resistance in type 2 diabetes\u2014role of the adipokines. Curr Mol Med. 2005;5:333\u20139.","journal-title":"Curr Mol Med"},{"key":"51_CR16","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","volume":"131","author":"H Tilg","year":"2006","unstructured":"Tilg H, Hotamisligil GS. Nonalcoholic fatty liver disease: cytokine\u2013adipokine interplay and regulation of insulin resistance. Gastroenterology. 2006;131:934\u201345.","journal-title":"Gastroenterology"},{"key":"51_CR17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1572-0241.2007.01709.x","volume":"103","author":"C Carter-Kent","year":"2008","unstructured":"Carter-Kent C, Zein NN, Feldstein AE. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Am J Gastroenterol. 2008;103:1036\u201342.","journal-title":"Am J Gastroenterol"},{"key":"51_CR18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.diabet.2007.08.002","volume":"34","author":"M Guerre-Millo","year":"2008","unstructured":"Guerre-Millo M. Adiponectin: an update. Diabetes Metab. 2008;34:12\u20138.","journal-title":"Diabetes Metab"},{"key":"51_CR19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1586\/17474124.2.1.47","volume":"2","author":"J Wang","year":"2008","unstructured":"Wang J, Brymora J, George J. Roles of adipokines in liver injury and fibrosis. Expert Rev Gastroenterol Hepatol. 2008;2:47\u201357.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"51_CR20","first-page":"46","volume":"40","author":"JM Hui","year":"2004","unstructured":"Hui JM, Hodge A, Farrell GC, et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology. 2004;40:46\u201354.","journal-title":"Hepatology"},{"key":"51_CR21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1365-2265.2004.01977.x","volume":"60","author":"A Lopez-Bermejo","year":"2004","unstructured":"Lopez-Bermejo A, Botas P, Funahashi T, et al. Adiponectin, hepatocellular dysfunction and insulin sensitivity. Clin Endocrinol (Oxf). 2004;60:256\u201363.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"51_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/gut.2003.037010","volume":"54","author":"S Kaser","year":"2005","unstructured":"Kaser S, Moschen A, Cayon A, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut. 2005;54:117\u201321.","journal-title":"Gut"},{"key":"51_CR23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.gastro.2004.10.047","volume":"128","author":"KV Kowdley","year":"2005","unstructured":"Kowdley KV, Pratt DS. Adiponectin\u2014tipping the scales from NAFLD to NASH? Gastroenterology. 2005;128:511\u20133 (author reply 513).","journal-title":"Gastroenterology"},{"key":"51_CR24","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1478-3231.2009.02022.x","volume":"29","author":"M Lemoine","year":"2009","unstructured":"Lemoine M, Ratziu V, Kim M, et al. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Liver Int. 2009;29:1431\u20138.","journal-title":"Liver Int"},{"issue":"9","key":"51_CR25","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1478-3231.2009.02119.x","volume":"29","author":"M Arrese","year":"2009","unstructured":"Arrese M, Riquelme A. The value of serum adipokine measurement in non-alcoholic fatty liver disease. Liver Int. 2009;29(9):1291\u20133.","journal-title":"Liver Int"},{"key":"51_CR26","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jc.2004-2240","volume":"90","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi E, Pagotto U, Manini R, et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab. 2005;90:3498\u2013504.","journal-title":"J Clin Endocrinol Metab"},{"key":"51_CR27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1478-3231.2005.01209.x","volume":"26","author":"NA Palekar","year":"2006","unstructured":"Palekar NA, Naus R, Larson SP, et al. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. Liver Int. 2006;26:151\u20136.","journal-title":"Liver Int"},{"key":"51_CR28","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1381\/0960892055002347","volume":"15","author":"C Boza","year":"2005","unstructured":"Boza C, Riquelme A, Ibanez L, et al. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass. Obes Surg. 2005;15:1148\u201353.","journal-title":"Obes Surg"},{"key":"51_CR29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","volume":"45","author":"M Machado","year":"2006","unstructured":"Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600\u20136.","journal-title":"J Hepatol"},{"key":"51_CR30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0016-5085(98)70266-5","volume":"115","author":"JF Miquel","year":"1998","unstructured":"Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology. 1998;115:937\u201346.","journal-title":"Gastroenterology"},{"key":"51_CR31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cld.2004.04.008","volume":"8","author":"CE Ruhl","year":"2004","unstructured":"Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis. 2004;8:501\u201319. vii.","journal-title":"Clin Liver Dis"},{"key":"51_CR32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cld.2007.02.014","volume":"11","author":"P Charatcharoenwitthaya","year":"2007","unstructured":"Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis. 2007;11:37\u201354. viii.","journal-title":"Clin Liver Dis"},{"key":"51_CR33","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/j.1572-0241.2007.01520.x","volume":"102","author":"P Mishra","year":"2007","unstructured":"Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol. 2007;102:2716\u20137.","journal-title":"Am J Gastroenterol"},{"key":"51_CR34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2337\/diacare.23.1.57","volume":"23","author":"E Bonora","year":"2000","unstructured":"Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57\u201363.","journal-title":"Diabetes Care"},{"key":"51_CR35","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.4067\/S0034-98872002001100004","volume":"130","author":"AM Acosta","year":"2002","unstructured":"Acosta AM, Escalona M, Maiz A, et al. Determination of the insulin resistance index by the homeostasis model assessment in a population of Metropolitan Region in Chile. Rev Med Chil. 2002;130:1227\u201331.","journal-title":"Rev Med Chil"},{"key":"51_CR36","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735\u201352.","journal-title":"Circulation"},{"key":"51_CR37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/gast.2003.50004","volume":"124","author":"CE Ruhl","year":"2003","unstructured":"Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003;124:71\u20139.","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"51_CR38","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc07-S004","volume":"30","author":"American Diabetes Association","year":"2007","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20142007. Diabetes Care. 2007;30 Suppl 1:S4\u201341.","journal-title":"Diabetes Care"},{"key":"51_CR39","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486\u201397.","journal-title":"JAMA"},{"key":"51_CR40","doi-asserted-by":"crossref","unstructured":"Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992;55:615S\u20139S","DOI":"10.1093\/ajcn\/55.2.615s"},{"key":"51_CR41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"51_CR42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","volume":"112","author":"A Xu","year":"2003","unstructured":"Xu A, Wang Y, Keshaw H, et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest. 2003;112:91\u2013100.","journal-title":"J Clin Invest"},{"key":"51_CR43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","volume":"27","author":"MH Jarrar","year":"2008","unstructured":"Jarrar MH, Baranova A, Collantes R, et al. Adipokines and cytokines in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2008;27:412\u201321.","journal-title":"Aliment Pharmacol Ther"},{"key":"51_CR44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.mcg.0000152747.79773.2f","volume":"39","author":"R Vuppalanchi","year":"2005","unstructured":"Vuppalanchi R, Marri S, Kolwankar D, et al. Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study. J Clin Gastroenterol. 2005;39:237\u201342.","journal-title":"J Clin Gastroenterol"},{"key":"51_CR45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/MCG.0b013e31819e9048","volume":"43","author":"S Savvidou","year":"2009","unstructured":"Savvidou S, Hytiroglou P, Orfanou-Koumerkeridou H. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD. J Clin Gastroenterol. 2009;43:765\u201372.","journal-title":"J Clin Gastroenterol"},{"key":"51_CR46","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s11695-008-9506-y","volume":"18","author":"ZM Younossi","year":"2008","unstructured":"Younossi ZM, Jarrar M, Nugent C, et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg. 2008;18:1430\u20137.","journal-title":"Obes Surg"},{"key":"51_CR47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1665-2681(19)31790-9","volume":"8","author":"LE Munoz","year":"2009","unstructured":"Munoz LE, Cordero P, Torres L, et al. Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis. Ann Hepatol. 2009;8:123\u20138.","journal-title":"Ann Hepatol"},{"key":"51_CR48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2265.2006.02466.x","volume":"64","author":"G Targher","year":"2006","unstructured":"Targher G, Bertolini L, Rodella S, et al. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2006;64:337\u201341.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"51_CR49","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/oby.2007.92","volume":"16","author":"JF Carroll","year":"2008","unstructured":"Carroll JF, Chiapa AL, Rodriquez M, et al. Visceral fat, waist circumference, and BMI: impact of race\/ethnicity. Obesity (Silver Spring). 2008;16:600\u20137.","journal-title":"Obesity (Silver Spring)"},{"key":"51_CR50","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00125-006-0384-3","volume":"49","author":"DK Richardson","year":"2006","unstructured":"Richardson DK, Schneider J, Fourcaudot MJ, et al. Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. Diabetologia. 2006;49:2317\u201328.","journal-title":"Diabetologia"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-009-0051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11695-009-0051-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-009-0051-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T16:12:48Z","timestamp":1590509568000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11695-009-0051-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,12]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1007\/s11695-009-0051-0","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,12]]}}}